Taegwon Oh

Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis

Kévin Pethe, Pablo Bifani, Jichan Jang et al. · Nature Medicine · 2013 · 595 citations · Full text

Medicinal Chemistry, Potent Clinical Candidate, Pulmonary Tuberculosis +7

High Content Screening Identifies Decaprenyl-Phosphoribose 2′ Epimerase as a Target for Intracellular Antimycobacterial Inhibitors

Thierry Christophe, Mary Jackson, Hee Kyoung Jeon et al. · PLoS Pathogens · 2009 · 322 citations · Full text

Antimicrobial Chemotherapy, Drug Resistance, Medicinal Chemistry +21

Macrolide Treatment for <i>Mycobacterium abscessus</i> and <i>Mycobacterium massiliense</i> Infection and Inducible Resistance

Go Eun Choi, Sung Jae Shin, Choul-Jae Won et al. · American Journal of Respiratory and Critical Care Medicine · 2012 · 192 citations

Design, Synthesis, and Structure–Activity Relationship Studies of Tryptanthrins As Antitubercular Agents

Jae-Min Hwang, Taegwon Oh, Takushi Kaneko et al. · Journal of Natural Products · 2013 · 126 citations · Full text

Pharmaceutical Science, Tryptanthrin Analogues, Biochemistry +13

Efficacy and Safety of Metronidazole for Pulmonary Multidrug-Resistant Tuberculosis

Matthew Carroll, Doosoo Jeon, James M. Mountz et al. · Antimicrobial Agents and Chemotherapy · 2013 · 81 citations · Full text

Peripheral Neuropathy, Pulmonary Tuberculosis, Antibiotics +12